Skip to content

Clinical trials

Phase 2/3 COVID-19 trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2/3 Country / region: Philippines Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20204
20212
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Clover Biopharmaceuticals AUS Pty1
National Institute of Allergy and Infectious Diseases (NIAID)1
Novavax1
Shanghai Henlius Biotech1
Shin Poong Pharmaceutical Co. Ltd.1
Suzhou Abogen Biosciences Co., Ltd.1
University of the Philippines1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-199
Coronaviridae Infections1
Coronavirus Infections1
Nidovirales Infections1
RNA Virus Infections1
Severe Acute Respiratory Syndrome1
Virus Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.